Andreas Selberherr is a Consultant Endocrine Surgeon at the General Hospital of the Medical University of Vienna and he is currently working with Professor Rajesh Thakker at the University of Oxford on epigenetic modifiers as therapeutic agents for neuroendocrine tumours. He completed his specialty training in general and visceral surgery in 2016 and became a Fellow of the European Board of Surgery in the field of Endocrine Surgery in 2017.